Area of research
Psychiatry and Mental health · Cognitive Neuroscience
Research interest
Research interests include Schizophrenia research and treatment, Functional Brain Connectivity Studies, Dementia and Cognitive Impairment Research, and Advanced Neuroimaging Techniques and Applications.
A novel spatiotemporal graph convolutional network framework for functional connectivity biomarkers identification of Alzheimer’s disease
Large-scale analysis of structural brain asymmetries in schizophrenia via the ENIGMA consortium
Deep learning-based polygenic risk analysis for Alzheimer’s disease prediction
Identifying canonical and replicable multi‐scale intrinsic connectivity networks in 100k+ <scp>resting‐state fMRI</scp> datasets
Prevalence and Clinical Implications of a β-Amyloid–Negative, Tau-Positive Cerebrospinal Fluid Biomarker Profile in Alzheimer Disease
Clozapine Optimization: A Delphi Consensus Guideline From the Treatment Response and Resistance in Psychosis Working Group
Reliability and clinical utility of spatially constrained estimates of intrinsic functional networks from very short <scp>fMRI</scp> scans
Cortical morphology in patients with the deficit and non-deficit syndrome of schizophrenia: a worldwide meta- and mega-analyses
An IL1RL1 genetic variant lowers soluble ST2 levels and the risk effects of APOE-ε4 in female patients with Alzheimer’s disease
Moving beyond the ‘CAP’ of the Iceberg: Intrinsic connectivity networks in fMRI are continuously engaging and overlapping
Longitudinal Associations of Blood Phosphorylated Tau181 and Neurofilament Light Chain With Neurodegeneration in Alzheimer Disease
A <scp>meta‐analysis</scp> of deep brain structural shape and asymmetry abnormalities in 2,833 individuals with schizophrenia compared with 3,929 healthy volunteers via the <scp>ENIGMA Consortium</scp>
Multi-spatial-scale dynamic interactions between functional sources reveal sex-specific changes in schizophrenia
Reward Processing in Novelty Seekers: A Transdiagnostic Psychiatric Imaging Biomarker
Spread of pathological tau proteins through communicating neurons in human Alzheimer’s disease
The neurobiology of treatment-resistant schizophrenia: paths to antipsychotic resistance and a roadmap for future research
Clinical Guidance on the Identification and Management of Treatment-Resistant Schizophrenia
Non-coding variability at the APOE locus contributes to the Alzheimer’s risk
The BIN1 rs744373 SNP is associated with increased tau-PET levels and impaired memory
The spatial chronnectome reveals a dynamic interplay between functional segregation and integration
Cortical Brain Abnormalities in 4474 Individuals With Schizophrenia and 5098 Control Subjects via the Enhancing Neuro Imaging Genetics Through Meta Analysis (ENIGMA) Consortium
Multimodal neuromarkers in schizophrenia via cognition-guided MRI fusion
Resting-state thalamic dysconnectivity in schizophrenia and relationships with symptoms
Salience–Default Mode Functional Network Connectivity Linked to Positive and Negative Symptoms of Schizophrenia
Spatial dynamics within and between brain functional domains: A hierarchical approach to study time‐varying brain function
Shared Genetic Risk of Schizophrenia and Gray Matter Reduction in 6p22.1
Characteristic patterns of inter- and intra-hemispheric metabolic connectivity in patients with stable and progressive mild cognitive impairment and Alzheimer’s disease
Maternal Systemic Interleukin-6 During Pregnancy Is Associated With Newborn Amygdala Phenotypes and Subsequent Behavior at 2 Years of Age
Prefrontal cortical thinning links to negative symptoms in schizophrenia via the ENIGMA consortium
Positive symptoms associate with cortical thinning in the superior temporal gyrus via the ENIGMA Schizophrenia consortium